Navigation Links
ExonHit Therapeutics - 2007 Financial Results
Date:3/5/2008

disease to market our first blood diagnostic for the detection of AD and to continue our clinical research program with our compound EHT0202.

I am very confident in the efforts of our teams to obtain GBEA accreditation of our two GLPS service laboratories in molecular biology, both in Paris and in Gaithersburg, to serve biomedical research and our own medical diagnostics in neurodegenerative diseases and cancers. This is a crucial step for our revenues to grow as early as 2009. In addition, in 2008, we will have the results of over 5 years of ongoing efforts with our partners, Allergan and bioMerieux, and the new management will endeavour to translate these results in realistic operational and marketing ambitions."

Overview of ExonHit's business activities

In order to better organise its operations and to increase its chances of building its revenues, the Company has implemented two commercial departments: "Molecular Diagnostic/Genomic Services" and "Therapeutics".

Each department shall have the necessary resources to reach its objectives, as well as large autonomy to determine those objectives. The R&D, for each department, will conduct the research and reach the objectives that will have been set.

Of course, there will be the two departments will be connected and information shared. To this end, a Strategy department has been created, which aims at ensuring the coherence and the long term objectives of the Company. This department will include Operations and Project organisation.

For 2008, Operations will concentrate their efforts on obtaining an accreditation to realise clinical diagnostics in Paris and Gaithersburg. It will also realise the services which ExonHit offers its customers in biomedical research, and continue the promotion of its tools both in the US and in Europe.

In 2008, the Company will continue to invest in its two fields of activity, both in partnership and in-house, in line with the projects init
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
2. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
3. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
4. ExonHit and bioMerieux Amend Their Strategic Partnership
5. ExonHit Builds A New Organisation
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Research and ... addition of Jain PharmaBiotech,s new report ... to their offering. The scope ... in situ hybridization (FISH), comparative genomic hybridization ... application of nanobiotechnology, microarrays, real-time polymerase chain ...
(Date:9/2/2015)... ... September 02, 2015 , ... Drug companies increasingly are adopting ... Research reveals in its new report that the U.S. will generate the greatest ... generates the most market demand. , BCC Research examines plant-derived drugs in ...
(Date:9/2/2015)... 2015 Australian prostate cancer technology company Minomic ... prize recognising ,outstanding, science that uses its patented antibody. ... a novel prostate cancer diagnostic test known as MiCheck® ... taking out the peer-reviewed Australian Museum Eureka Science Prize ... This prize is awarded for ground breaking research ...
(Date:9/2/2015)... , Sept. 2, 2015 Veracyte, Inc. ... H. Anderson , president and chief executive officer, will ... Wednesday, September 16, 2015 at 10:30 a.m. ET in ... The live audio webcast and subsequent replay may ... webcast will be available shortly after conclusion of the ...
Breaking Biology Technology:Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2
... (NYSE: BRL ) today confirmed that its ... the patent listed by Forest,Laboratories, Inc. in connection ... Barr filed its Abbreviated New Drug Application ... Namenda product with the U.S. Food,& Drug Administration ...
... 11 Maxygen, Inc.,(Nasdaq: MAXY ), a ... drugs, today announced that it will present at ... Thursday,January 17, 2008 at 7:45 a.m. Eastern Time. ... live webcast of the presentation can be,accessed on ...
... ATLANTA, Jan. 11 CryoLife, Inc. (NYSE: CRY ... that it has been notified that a lawsuit will ... County, Georgia relating to a meniscal,allograft., The lawsuit ... of a meniscal allograft in December 2006. Meniscal,transplants are ...
Cached Biology Technology:Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg 2Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg 3CryoLife Responds to Inaccurate Assertions from Plaintiff's Attorney 2CryoLife Responds to Inaccurate Assertions from Plaintiff's Attorney 3
(Date:8/6/2015)... CITY, Calif. , Aug. 6, 2015 /PRNewswire/ ... Valley) will visit Crossmatch ™ to learn ... networks and protect data. Crossmatch is a world ... whose technologies and expertise are helping federal agencies ... efficiency and security.   "The vast ...
(Date:8/5/2015)... New York , August 5, 2015 ... market report titled "Facial Recognition Market - Global Industry ... 2022", the global market for facial recognition is forecast ... is driven by increased demand for surveillance systems by ... the rising number of crimes and terrorist activities across ...
(Date:8/3/2015)... Synaptics, Inc. (Nasdaq: SYNA ), the ... members of the executive management team will present to ... Leadership Forum on Tuesday, August 11, 2015 at 1:00 ... the Sonnenalp Resort in Vail, CO. ... information. An audio webcast of the event will be ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
... SPRING HARBOR, N.Y. How many genes are in the ... How many mobile elements, simple sequence repeats, or protein kinases ... and proteins" How similar are human proteins to those of ... A Short Guide to the Human Genome , answers these and ...
... -- As the Nobel Foundation recognizes the 55th anniversary ... newly formed Rosalind Franklin Society celebrates the contribution of ... breakthrough possible. Although Franklin was not included ... Crick, the late Maurice Wilkins, and James Watson for ...
... of California, Santa Barbara will receive $3.2 million from ... of the development of a state-of-the-art facility in the ... at UCSB, according to an announcement by CIRM today. ... million. A website about the center is located at: ...
Cached Biology News:UCSB receives $3.2 million stem cell grant from state 2UCSB receives $3.2 million stem cell grant from state 3
... Simultaneously perform 96 assays on four slides. ... microarray slides with 96 (6mm x 7mm) ... gene expression, or screening analysis studies. Unlike ... fit gasket, eliminating the presence of contaminating ...
... of Use : GeneTraffic is built to ... biological research. GeneTraffic provides visual and computational ... data prior to analysis. , Data ... projects using the MIAME (Minimum Information About ...
... siTrio siRNA --- a cocktail of 3 ... of interestis our most popular product. The ... 75% knockdown of your target gene when ... for transfection and confirmation of optimal transfection ...
... kit #27295 has improved stability and convenience from ... not only has overcome this problem but also ... have changed the formulation of HRP conjugated antibody ... By this change, the stability of the conjugate ...
Biology Products: